Correlation Between Allogene Therapeutics and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Caribou Biosciences, you can compare the effects of market volatilities on Allogene Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Caribou Biosciences.
Diversification Opportunities for Allogene Therapeutics and Caribou Biosciences
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Allogene and Caribou is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Caribou Biosciences
Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Caribou Biosciences. In addition to that, Allogene Therapeutics is 1.09 times more volatile than Caribou Biosciences. It trades about -0.05 of its total potential returns per unit of risk. Caribou Biosciences is currently generating about -0.01 per unit of volatility. If you would invest 221.00 in Caribou Biosciences on August 25, 2024 and sell it today you would lose (19.00) from holding Caribou Biosciences or give up 8.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.46% |
| Values | Daily Returns |
Allogene Therapeutics vs. Caribou Biosciences
Performance |
| Timeline |
| Allogene Therapeutics |
| Caribou Biosciences |
Allogene Therapeutics and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Caribou Biosciences
The main advantage of trading using opposite Allogene Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |